The Association With Peptic Ulcer Disease and Hepatic Vein Pressure Gradient

Chuncheon Sacred Heart Hospital

Status: Completed

Conditions: Chronic Liver Disease; Cirrhosis

Study type: Observational

Funder types: Other

Identifiers

NCT01944878

BCS-1

Details and patient eligibility

About

The aim of this study is to assess the role of portal hypertension of peptic ulcer disease in liver cirrhosis and chronic hepatitis.

Full description

Retrospective case-control study

• Investigators will analyze the medical records of hepatic vein pressure gradient (HVPG) and esophagogastroduodenoscopy (EGD) cases who had liver cirrhosis (LC) or chronic hepatitis in a single tertiary hospital (Chuncheon Sacred Heart hospital, Korea) within 2008~2012.
• Portal hypertension is assessed using HVPG measurement via transjugular approach.
• Peptic ulcer is evaluated through EGD within 3 months of HVPG measurement
• The association of Peptic ulcer with LC, chronic hepatitis and total population (LC or chronic hepatitis) will be assessed by univariate and multivariate analysis
• There is no specific time frame, because this study is retrospective observational study, however EGD data is enrolled if it was done within 3 month from HVPG measurement.

Enrollment: 455 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• The patients who underwent hepatic vein pressure gradient (HVPG) measurement and esophagogastroduodenoscopy (EGD) and also had LC or chronic hepatitis

Exclusion criteria

• The patients who have missing or incomplete HVPG or EGD data
• The patients who underwent gastrectomy
• The patients who have systemic malignancy

Trial design

455 participants in 2 patient groups

Patients with chronic hepatitis

Description:

Patients with chronic hepatitis, who experienced HVPG measurement via transjugular approach and EGD within 3 months of HVPG measurement

Patients with liver cirrhosis

Description:

Patients with liver cirrhosis, who experienced HVPG measurement via transjugular approach and EGD within 3 months of HVPG measurement